 Urologic sarcoma adults Memorial Sloan-Kettering Cancer Center experience prospective database Urologic sarcoma group rare tumors poor prognosis sarcomas share prognostic characteristics soft-tissue sarcomas sites staging system tumor grade size valuable patients high risk disease Patients sarcomas high-grade cm diameter metastatic time presentation MSKCC relapse-free survival rate Complete surgical resection negative margins chance cure reasons clear multimodality therapy rhabdomyosarcoma effective adult pediatric disease Present-day chemotherapeutic regimens ineffective disseminated sarcoma adoption uniform staging system multi-institutional collaboration progress deadly form genitourinary cancer